Reklama
WIG82 745,58+1,45%
WIG202 436,05+1,72%
EUR / PLN4,31+0,04%
USD / PLN4,00+0,16%
CHF / PLN4,43+0,07%
GBP / PLN5,05+0,15%
EUR / USD1,08-0,12%
DAX18 492,49+0,08%
FT-SE7 952,60+0,26%
CAC 408 205,81+0,01%
DJI39 807,37+0,12%
S&P 5005 254,35+0,11%
ROPA BRENT87,07+1,60%
ROPA WTI82,70+1,20%
ZŁOTO2 234,24+0,06%
SREBRO25,03+1,87%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

komunikat spółki espi SOPHARMA AD 2022-10-05 13:01

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No82/2022
Date of issue:2022-10-05
Short name of the issuer
SOPHARMA AD
Subject
Sales revenues for September 2022
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that for September 2022 the Company recorded a decrease in sales of 36% compared to the same month of the previous year, incl. 54% decrease in domestic sales and 23% decrease in export sales.
Annexes
FileDescription
Sales_Revenues_for_September_2022_espi.pdfSales revenues for September 2022
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2022-10-05Ognian DonevExecutive director
Czytaj więcej

Artykuły związane z komunikat spółki espi SOPHARMA AD 2022-10-05 13:01